Draft Genome Sequences of Streptococcus pneumoniae with High-Level Resistance to Respiratory Fluoroquinolones.
Genome Announc, 2016/3/31;4(2)
Keness Y[1], Bisharat N[2]
Affiliations
PMID: 27034491
Abstract
Streptococcus pneumoniaeis the leading cause of community-acquired pneumonia. Levofloxacin is a fluoroquinolone used for treatment of severe community-acquired pneumonia. Here, we describe the draft genome sequences ofS. pneumoniaewith emerging resistance to levofloxacin, resulting in failure of treatment of pneumococcal pneumonia.
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download